AGP Executive Report
Last update: 2 hours agoPublic Transport & Tourism: Macau’s “Leisure Tour Bus 2.0” carried nearly 37,000 passengers by mid-August, with added Friday routes making up about one-third of summer boarding; authorities are now weighing whether to make the service permanent, while a mobile info platform upgrade doubled views to 60,000. Regional Connectivity: At the Greater Bay Area Conference 2026 in Hong Kong, officials framed the GBA as a new Asia-Pacific connectivity engine, with Hong Kong highlighted as a “super connector” amid fast-changing geopolitics and technology. Biotech Deal: GSK is paying up to about US$1.3B for HUTCHMED’s HMPL-A830, a KRAS-EGFR antibody-targeted therapy conjugate, aiming at colorectal, pancreatic and lung cancers; the deal includes a US$110M upfront payment and milestones, with HUTCHMED retaining control in mainland China, Hong Kong, Macau and Taiwan. Low-Altitude Tech: Macau is testing drone deliveries for medical samples, targeting 10–15 minute trips between Conde de São Januário Hospital and Peking Union Medical College Hospital’s Macao Medical Center, while noting airspace and standards hurdles. Smart Grid Research: PolyU launched InnoHK I-GET to build an intelligent grid and energy-tech research push for carbon-neutral goals. Macau Finance: Monetary Authority data shows broad money supply rebounded in July, with M2 up 1.5% to MOP860.5B.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
